Literature DB >> 24739856

Blood stream infection by an emerging pathogen Oligella ureolytica in a cancer patient: case report and review of literature.

Frincy K Baruah1, Monica Jain, Mamta Lodha, Rajesh K Grover.   

Abstract

Oligella ureolytica is an emerging bacteria rarely implicated as a human pathogen. It is infrequently recovered from clinical specimens probably because of inadequate processing of non-fermenting oxidase positive Gram negative bacilli. We present here a case of a 30 year old male suffering from right lung adenocarcinoma (moderately differentiated) with multiple abdominal lymph node metastasis with Syringohydromyelia whose blood culture yielded Oligella ureolytica in pure culture. Oligella ureolytica isolation in pure culture and the patient's response to targeted treatment supported that Oligella ureolytica was the true causative agent of the blood stream infection. Early suspicion, diagnosis and treatment with potent antibiotics are needed to prevent further complications resulting from infection with this emerging pathogen.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739856     DOI: 10.4103/0377-4929.130928

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  A Multi-Omics Study of Familial Lung Cancer: Microbiome and Host Gene Expression Patterns.

Authors:  Ying Chen; Yunchao Huang; Xiaojie Ding; Zhenlin Yang; Liang He; Mingjie Ning; Zhenghong Yang; Daqian He; Lijuan Yang; Zhangyi Liu; Yan Chen; Guangjian Li
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

2.  Oligella ureolytica Bacteremia in Elderly Woman, United States.

Authors:  Tristan Simmons; Eryn Fennelly; David Loughran
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

3.  Extra benefit of microalgae in raw piggery wastewater treatment: pathogen reduction.

Authors:  Sang-Ah Lee; Minsik Kim; Hee-Sik Kim; Chi-Yong Ahn
Journal:  Microbiome       Date:  2022-08-31       Impact factor: 16.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.